packageTafamidis

tafamidis

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tafamidis is a nervous system drug used to treat amyloidosis. It is authorised in the European Union and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q519447 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tafamidis
ATC codes:N07XX08
DrugBank:DB11644
PubChem CID:11001318
ChEBI:78538
Wikidata:Q519447
formula:C14H7Cl2NO3
molar mass:308.114 g/mol (PubChem CID 11001318)
logP:4.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown